Role of amyloid beta in lipid homeostasis

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · see citing works

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · see citing works

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · see citing works

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · see citing works

Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease

Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786 · see citing works

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works

Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts

Brown, D. A., & London, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000005200 · Cited by 2,344 · see citing works

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234 · see citing works

Mammalian Transcription Factor ATF6 Is Synthesized as a Transmembrane Protein and Activated by Proteolysis in Response to Endoplasmic Reticulum Stress

Haze, K., Yoshida, H., Yanagi, H., Yura, T., & Mori, K. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.11.3787 · Cited by 2,073 · see citing works

The Enzymes, Regulation, and Genetics of Bile Acid Synthesis

Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069 · see citing works

Amyloid β-peptide is produced by cultured cells during normal metabolism

Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · see citing works

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · see citing works

Statins and the risk of dementia

Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,763 · see citing works

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525 · see citing works

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G., & Siegel, G. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,499 · see citing works

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478 · see citing works

Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons

Simons, M., Keller, P., Strooper, B. D., Beyreuther, K. T., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,167 · see citing works

Constitutive and regulated α-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease

Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., & Fahrenholz, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3922 · Cited by 1,132 · see citing works

Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

Fassbender, K. C., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 1,078 · see citing works

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα

Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005 · see citing works

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J. J., Bryant‐Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 1,003 · see citing works

Intraneuronal Aβ42 Accumulation in Human Brain

Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · see citing works

Alzheimer's disease: the cholesterol connection

Puglielli, L., Tanzi, R. E., & Kovacs, D. M. (2003) · Nature Neuroscience · doi:10.1038/nn0403-345 · Cited by 864 · see citing works

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10

Kojro, E., Gimpl, G., Lammich, S., März, W., & Fahrenholz, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081612998 · Cited by 804 · see citing works

ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study: A Randomized Double-blind Trial

Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751 · see citing works

Untitled work

(1985) · PubMed · Cited by 706 · see citing works

Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides

Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 706 · see citing works

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693 · see citing works

Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

Notkola, I.-L., Sulkava, R. O., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 666 · see citing works

Apolipoprotein E ε4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease

Kivipelto, M., Helkala, E., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A. M., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 645 · see citing works

The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway

Haass, C., Lemere, C. A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., & Selkoe, D. J. (1995) · Nature Medicine · doi:10.1038/nm1295-1291 · Cited by 592 · see citing works

Acute cholesterol depletion inhibits clathrin-coated pit budding

Subtil, A., Gaidarov, I., Kobylarz, K. A., Lampson, M. A., Keen, J. H., & McGraw, T. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6775 · Cited by 577 · see citing works

Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later

Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000231980 · Cited by 557 · see citing works

Isoform-specific binding of apolipoprotein E to beta-amyloid.

LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540 · see citing works

A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Refolo, L. M., Pappolla, M. A., LaFrancois, J. J., Malester, B., Schmidt, S. D., Thomas-Bryant, T., Tint, G. S., Wang, R., Mercken, M. H., Petanceska, S. S., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0422 · Cited by 521 · see citing works

Deregulation of sphingolipid metabolism in Alzheimer’s disease

He, X., Huang, Y., Li, B., Gong, C.-X., & Schuchman, E. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.010 · Cited by 516 · see citing works

LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation

Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T., & Strickland, D. K. (1995) · Cell · doi:10.1016/0092-8674(95)90320-8 · Cited by 489 · see citing works

Total inactivation of γ–secretase activity in presenilin-deficient embryonic stem cells

Herreman, A., Serneels, L., Annaert, W. G., Collen, D., Schoonjans, L., & Strooper, B. D. (2000) · Nature Cell Biology · doi:10.1038/35017105 · Cited by 481 · see citing works

Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide

Puglielli, L., Konopka, G., Pack-Chung, E., Ingano, L. A. M., Berezovska, O., Hyman, B. T., Chang, T., Tanzi, R. E., & Kovacs, D. M. (2001) · Nature Cell Biology · doi:10.1038/ncb1001-905 · Cited by 470 · see citing works

Complementation Cloning of , a Gene Encoding a Putative Metalloprotease Required for Intramembrane Cleavage of SREBPs

Rawson, R. B., Zelenski, N. G., Nijhawan, D., Ye, J., Sakai, J., Hasan, M. T., Chang, T., Brown, M. S., & Goldstein, J. L. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80006-4 · Cited by 466 · see citing works

Cholesterol Modulates α-Secretase Cleavage of Amyloid Precursor Protein

Bodovitz, S., & Klein, W. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4436 · Cited by 447 · see citing works

Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin

Grimm, M. O. W., Grimm, H. S., Pätzold, A. J., Zinser, E. G., Halonen, R., Duering, M., Tschäpe, J., Strooper, B. D., Müller, U., Shen, J., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1313 · Cited by 446 · see citing works

Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

(1994) · PubMed Central · Cited by 441 · see citing works

Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells

Cook, D. G., Forman, M. S., Sung, J. C., Leight, S., Kolson, D. L., Iwatsubo, T., Lee, V. M.-Y., & Doms, R. W. (1997) · Nature Medicine · doi:10.1038/nm0997-1021 · Cited by 439 · see citing works

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

Feldman, H. H., Doody, R. S., Kivipelto, M., Sparks, D. L., Waters, D. D., Jones, R. W., Schwam, E., Schindler, R., Hey-Hadavi, J., DeMicco, D. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d6476a · Cited by 438 · see citing works

Clearance of amyloid-β by circulating lipoprotein receptors

Sagare, A. P., Deane, R., Bell, R. D., Johnson, B., Hamm, K., Pendu, R., Marky, A. H., Lenting, P. J., Wu, Z., Zarcone, T. J., et al. (2007) · Nature Medicine · doi:10.1038/nm1635 · Cited by 428 · see citing works

Cholesterol-Dependent γ-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains

Schindler, S. E., Das, P., Nyborg, A. C., McLendon, C., Shoji, M., Kawarabayashi, T., Younkin, L. H., Younkin, S. G., & Golde, T. E. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0470 · Cited by 426 · see citing works

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial

Simons, M., Schwärzler, F., Lütjohann, D., von Bergmann, K., Beyreuther, K. T., DICHGANS, J., Wormstall, H., Hartmann, T., & Schulz, J. B. (2002) · Annals of Neurology · doi:10.1002/ana.10292 · Cited by 415 · see citing works

Maturation and Endosomal Targeting of β-Site Amyloid Precursor Protein-cleaving Enzyme

Huse, J. T., Pijak, D. S., Leslie, G. J., Lee, V. M.-Y., & Doms, R. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004175200 · Cited by 402 · see citing works

Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease

Sparks, D. L., Sabbagh, M. N., Connor, D. J., Lopez, J., Launer, L. J., Browne, P. J., Wasser, D., Johnson‐Traver, S., Lochhead, J. J., & Ziolwolski, C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.753 · Cited by 392 · see citing works

A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth

Small, D. H., Nurcombe, V., Reed, G., Clarris, H. J., Moir, R. D., Beyreuther, K. T., & Masters, C. L. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02117.1994 · Cited by 389 · see citing works

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

Wolozin, B. L., Wang, S. W., Li, N.-C., Lee, A. F., Lee, T. A., & Kazis, L. E. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-20 · Cited by 385 · see citing works

Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain

Hirsch-Reinshagen, V., Zhou, S., Burgess, B. L., Bernier, L., McIsaac, S. A., Chan, J. Y., Tansley, G. H., Cohn, J. S., Hayden, M. R., & Wellington, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407962200 · Cited by 385 · see citing works

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

Lütjohann, D., Papassotiropoulos, A., Björkhem, I., Locatelli, S., Bagli, M., Oehring, R. D., Schlegel, U. S., Jessen, F., Rao, M. L., von Bergmann, K., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32052-6 · Cited by 378 · see citing works

Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer β-amyloid peptides

Greenfield, J. P., Tsai, J., Gouras, G. K., Hai, B., Thinakaran, G., Checler, F., Sisodia, S. S., Greengard, P., & Xu, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.742 · Cited by 366 · see citing works

Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1

Liu, Q., Zerbinatti, C. V., Zhang, J., Hoe, H.-S., Wang, B., Cole, S. L., Herz, J., Muglia, L., & Bu, G. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.008 · Cited by 364 · see citing works

Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein

Cordy, J. M., Hussain, I., Dingwall, C., Hooper, N. M., & Turner, A. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1635130100 · Cited by 356 · see citing works

Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice

Méziane, H., Dodart, J., Mathis, C., Little, S. H., Clemens, J. A., Paul, S. M., & Ungerer, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12683 · Cited by 355 · see citing works

Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP).

Slunt, H. H., Thinakaran, G., von Koch, C., Lo, A., Tanzi, R. E., & Sisodia, S. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41992-2 · Cited by 346 · see citing works

Untitled work

(1981) · PubMed · Cited by 341 · see citing works

Evidence that Aβ42 is the real culprit in alzheimer's disease

Younkin, S. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370303 · Cited by 331 · see citing works

Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II)

Svennerholm, L. T., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 327 · see citing works

The role of cholesterol in the biosynthesis of β-amyloid.

Frears, E. R., Stephens, D. J., Walters, C. E., Davies, H., & Austen, B. (1999) · Neuroreport · doi:10.1097/00001756-199906030-00014 · Cited by 324 · see citing works

Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts

Riddell, D. R., Christie, G., Hussain, I., & Dingwall, C. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00394-3 · Cited by 303 · see citing works

Lipids as Modulators of Proteolytic Activity of BACE

Kalvodova, L., Kahya, N., Schwille, P., Ehehalt, R., Verkade, P., Drechsel, D. N., & Simons, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504484200 · Cited by 289 · see citing works

Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production

Xiong, H., Callaghan, D., Jones, A., Walker, D. G., Lue, L., Beach, T. G., Sue, L. I., Woulfe, J., Xu, H., Stanimirovic, D. B., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.10.005 · Cited by 283 · see citing works

Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target

Ye, S., Huang, Y., Müllendorff, K., Dong, L., Giedt, G., Meng, E. C., Cohen, F. E., Kuntz, I. D., Weisgraber, K. H., & Mahley, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508693102 · Cited by 275 · see citing works

Efficient Inhibition of the Alzheimer's Disease β-Secretase by Membrane Targeting

Rajendran, L., Schneider, A., Schlechtingen, G., Weidlich, S., Ries, J., Braxmeier, T. M., Schwille, P., Schulz, J. B., Schroeder, C., Simons, M., et al. (2008) · Science · doi:10.1126/science.1156609 · Cited by 262 · see citing works

Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain

Ginsberg, L., Rafique, S., Xuereb, J. H., Rapoport, S. I., & Gershfeld, N. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00931-f · Cited by 248 · see citing works

Inhibition of Intracellular Cholesterol Transport Alters Presenilin Localization and Amyloid Precursor Protein Processing in Neuronal Cells

Runz, H., Rietdorf, J., Tomic, I., de Bernard, M., Beyreuther, K. T., Pepperkok, R., & Hartmann, T. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01679.2002 · Cited by 242 · see citing works

Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease?

Katsel, P., Li, C., & Haroutunian, V. H. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9297-x · Cited by 240 · see citing works

Role of ATP‐binding cassette transporters in brain lipid transport and neurological disease

Kim, W. S., Weickert, C., & Garner, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05099.x · Cited by 240 · see citing works

Decrease and Structural Modifications of Phosphatidylethanolamine Plasmalogen in the Brain with Alzheimer Disease

Guan, Z., Wang, Y., Cairns, N. J., Lantos, P. L., Dallner, G., & Sindelar, P. J. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00008 · Cited by 236 · see citing works

The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease

Hirsch-Reinshagen, V., Maia, L. F., Burgess, B. L., Blain, J.-F., Naus, K. E., McIsaac, S. A., Parkinson, P. F., Chan, J. Y., Tansley, G. H., Hayden, M. R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508781200 · Cited by 233 · see citing works

Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides.

Wertkin, A. M., Turner, R. S., Pleasure, S. J., Golde, T. E., Younkin, S. G., Trojanowski, J. Q., & Lee, V. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9513 · Cited by 231 · see citing works

Meat‐Adaptive Genes and the Evolution of Slower Aging in Humans

Finch, C. E., & Stanford, C. B. (2004) · The Quarterly Review of Biology · doi:10.1086/381662 · Cited by 214 · see citing works

Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in culture

Araki, W., Kitaguchi, N., Tokushima, Y., Ishii, K., Aratake, H., Shimohama, S., Nakamura, S., & Kimura, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81412-3 · Cited by 213 · see citing works

Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

Malaplate, C., Florent‐Béchard, S., Youssef, I., Koziel, V., Sponne, I., Kriem, B., Leininger‐Muller, B., Olivier, J. L., Oster, T., & Pillot, T. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.010 · Cited by 213 · see citing works

ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD

Bryleva, E. Y., Rogers, M. A., Chang, C. C. Y., Buen, F., Harris, B. T., Rousselet, E., Seidah, N. G., Oddo, S., LaFerla, F. M., Spencer, T. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913828107 · Cited by 209 · see citing works

The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms☆

Finch, C. E., & Sapolsky, R. M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00053-6 · Cited by 204 · see citing works

Secreted β-Amyloid Precursor Protein Counteracts the Proapoptotic Action of Mutant Presenilin-1 by Activation of NF-κB and Stabilization of Calcium Homeostasis

Guo, Q., Robinson, N., & Mattson, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12341 · Cited by 196 · see citing works

Fibrillar Amyloid-β Peptides Kill Human Primary Neurons via NADPH Oxidase-mediated Activation of Neutral Sphingomyelinase

Jana, A., & Pahan, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404635200 · Cited by 184 · see citing works

Specific Regional Transcription of Apolipoprotein E in Human Brain Neurons

Xu, P., Gilbert, J. R., Qiu, H.-L., Ervin, J. F., Rothrock‐Christian, T., Hulette, C., & Schmechel, D. E. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65305-9 · Cited by 177 · see citing works

Structural Studies of the Transmembrane C-Terminal Domain of the Amyloid Precursor Protein (APP): Does APP Function as a Cholesterol Sensor?

Beel, A. J., Mobley, C. K., Kim, H. J., Tian, F., Hadziselimovic, A., Jap, B. K., Prestegard, J. H., & Sanders, C. R. (2008) · Biochemistry · doi:10.1021/bi800993c · Cited by 173 · see citing works

Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances β-Amyloid ProductionIn Vivo

Burns, M. P., Gaynor, K., Olm, V., Mercken, M. H., LaFrancois, J. J., Wang, L., Mathews, P. M., Noble, W. J., Matsuoka, Y., & Duff, K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05645.2003 · Cited by 172 · see citing works

Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons

Simons, M., Strooper, B. D., Multhaup, G., Tienari, P. J., Dotti, C. G., & Beyreuther, K. T. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-00899.1996 · Cited by 161 · see citing works

Accumulation and Aggregation of Amyloid β-Protein in Late Endosomes of Niemann-Pick Type C Cells

Yamazaki, T., Chang, T., Haass, C., & Ihara, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009598200 · Cited by 156 · see citing works

Alzheimer Disease Aβ Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts

Vetrivel, K. S., Meckler, X., Chen, Y., Nguyen, P. D., Seidah, N. G., Vassar, R., Wong, P. C., Fukata, M., Kounnas, M. Z., & Thinakaran, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808920200 · Cited by 153 · see citing works

Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content

Racchi, M., Baetta, R., Salvietti, N., Ianna, P., Franceschini, G., Paoletti, R., Fumagalli, R., Govoni, S. M., Trabucchi, M., & Soma, M. R. (1997) · Biochemical Journal · doi:10.1042/bj3220893 · Cited by 151 · see citing works

ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease

Wollmer, M. A. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00094-5 · Cited by 147 · see citing works

Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease

Kölsch, H., Lütjohann, D., Ludwig, M. Z., Schulte, A., Ptok, U., Jessen, F., von Bergmann, K., Rao, M. L., Maier, W., & Heun, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001109 · Cited by 139 · see citing works

Neural membrane phospholipids in alzheimer disease

Wells, K., Farooqui, A., Liss, L., & Horrocks, L. (1995) · Neurochemical Research · doi:10.1007/bf00992508 · Cited by 139 · see citing works

Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons

Tienari, P. J., Ida, N., Ikonen, E., Simons, M., Weidemann, A., Multhaup, G., Masters, C. L., Dotti, C. G., & Beyreuther, K. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4125 · Cited by 138 · see citing works

Presenilin-1 deficiency leads to loss of Cajal–Retzius neurons and cortical dysplasia similar to human type 2 lissencephaly

Hartmann, D., Strooper, B. D., & Säftig, P. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80331-5 · Cited by 136 · see citing works

Novel β-Secretase Cleavage of β-Amyloid Precursor Protein in the Endoplasmic Reticulum/Intermediate Compartment of NT2N Cells

Chyung, A. S. C., Greenberg, B., Cook, D. G., Doms, R. W., & Lee, V. M. ‐. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.3.671 · Cited by 136 · see citing works

The beta‐amyloid domain is essential for axonal sorting of amyloid precursor protein.

Tienari, P. J., Strooper, B. D., Ikonen, E., Simons, M., Weidemann, A., Czech, C., Hartmann, T., Ida, N., Multhaup, G., Masters, C. L., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00907.x · Cited by 131 · see citing works

ApoE immunoreactivity and microglial cells in Alzheimer’s disease brain

Uchihara, T., Duyckaerts, C., He, Y., Kobayashi, K., Seilhean, D., Amouyel, P., & Hauw, J.-J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11763-m · Cited by 131 · see citing works

Independent Inhibition of Alzheimer Disease β- and γ-Secretase Cleavage by Lowered Cholesterol Levels

Grimm, M. O. W., Grimm, H. S., Tomic, I., Beyreuther, K. T., Hartmann, T., & Bergmann, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801520200 · Cited by 128 · see citing works

The Search for α-Secretase and its Potential as a Therapeutic Approach to Alzheimer's Disease

Hooper, N. M., & Turner, A. J. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023370121 · Cited by 127 · see citing works

Increased Expression of Neuronal Apolipoprotein E in Human Brain With Cerebral Infarction

Aoki, K., Uchihara, T., Sanjo, N., Nakamura, A., Ikeda, K., Tsuchiya, K., & Wakayama, Y. (2003) · Stroke · doi:10.1161/01.str.0000064320.73388.c6 · Cited by 108 · see citing works

Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family

Cam (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-8 · Cited by 106 · see citing works

A nontransgenic mouse model shows inducible amyloid-β (Aβ) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade

Dolev, I., & Michaelson, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404458101 · Cited by 102 · see citing works

Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer’s disease: a tale of shotgun lipidomics

Han, X. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04708.x · Cited by 101 · see citing works

GM1 ganglioside regulates the proteolysis of amyloid precursor protein

Zha, Q., Ruan, Y., Hartmann, T., Beyreuther, K. T., & Zhang, D. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001509 · Cited by 100 · see citing works

Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway

Galbete, J. L., Martin, T. R., PERESSINI, E., Modena, P., Bianchi, R., & Forloni, G. (2000) · Biochemical Journal · doi:10.1042/bj3480307 · Cited by 97 · see citing works

Apolipoprotein E. Structure, Function, and Possible Roles in Alzheimer's Diseasea

Mahley, R. W., Nathan, B. P., & Pitas, R. E. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34412.x · Cited by 92 · see citing works

Modulation of Amyloid Precursor Protein Cleavage by Cellular Sphingolipids*

Sawamura, N., Ko, M., Yu, W., Zou, K., Hanada, K., Suzuki, T., Gong, J., Yanagisawa, K., & Michikawa, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309832200 · Cited by 88 · see citing works

Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons

Morimoto, T., Ohsawa, I., Takamura, C., Ishiguro, M., & Kohsaka, S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980115)51:2 · Cited by 85 · see citing works

Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons

Schneider, A., Schulz‐Schaeffer, W., Hartmann, T., Schulz, J. B., & Simons, M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.015 · Cited by 84 · see citing works

APP intracellular domain is increased and soluble Aβ is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease

George, A. J., Holsinger, R. M. D., McLean, C., Laughton, K. M., Beyreuther, K. T., Evin, G. M., Masters, C. L., & Li, Q. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.009 · Cited by 83 · see citing works

Pharmacological concentrations of the HMG-COA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta -amyloid peptide em in vitro em and in patients

Buxbaum, J. D. (2002) · Frontiers in bioscience · doi:10.2741/a739 · Cited by 82 · see citing works

Gangliosides in Cerebrospinal Fluid in 'Probable Alzheimer's Disease'

Blennow, K., Davidsson, P., Wallin, A., Fredman, P., Gottfries, C. G., Karlsson, I., Månsson, J., & Svennerholm, L. T. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530220048018 · Cited by 81 · see citing works

Amyloid‐β peptide enhances tumor necrosis factor‐α‐induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes

Zeng, C., Lee, J. T., Chen, H., Chen, S., Hsu, C. Y., & Xu, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03217.x · Cited by 80 · see citing works

Formation of Amyloids by Aβ-(1–42) on NGF-differentiated PC12 Cells: Roles of Gangliosides and Cholesterol

Wakabayashi, M., & Matsuzaki, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.008 · Cited by 70 · see citing works

S-Palmitoylation of γ-Secretase Subunits Nicastrin and APH-1

Cheng, H., Vetrivel, K. S., Drisdel, R. C., Meckler, X., Gong, P., Leem, J. Y., Li, T., Carter, M., Chen, Y., Nguyen, P. A. H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806380200 · Cited by 70 · see citing works

Impact of cholesterol level upon APP and BACE proximity and APP cleavage

Arnim, C. A. F. V., von Einem, B., Weber, P., Wagner, M., Schwanzar, D., Spoelgen, R., Strauß, W. S. L., & Schneckenburger, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.047 · Cited by 61 · see citing works

Cholesterol accumulation in Niemann Pick type C (NPC) model cells causes a shift in APP localization to lipid rafts

Košiček, M., Malnar, M., Goate, A., & Hecimovic, S. K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.007 · Cited by 60 · see citing works

Ceramide Involvement in Apoptosis and Apoptotic Diseases

Thevissen, K., François, I., Winderickx, J., Pannecouque, C. C., & Cammue, B. P. A. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706777435643 · Cited by 59 · see citing works

Oxidative stress induced by beta-amyloid peptide1–42 is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells

Qi, X., Xiu, J., Shan, K.-R., Xiao, Y. C., Gu, R., Liu, R., & Guan, Z.-Z. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.02.007 · Cited by 56 · see citing works

The Transmembrane Domain of the Amyloid Precursor Protein in Microsomal Membranes Is on Both Sides Shorter than Predicted

Grziwa, B., Grimm, M. O. W., Masters, C. L., Beyreuther, K. T., Hartmann, T., & Lichtenthaler, S. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210047200 · Cited by 51 · see citing works

Closing in on γ-secretase

Strooper, B. D. (2000) · Nature · doi:10.1038/35015193 · Cited by 51 · see citing works

Altered membrane fluidity and lipid raft composition in presenilin-deficient cells

Grimm, M. O. W., Tschäpe, J., Grimm, H. S., Zinser, E. G., & Hartmann, T. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00682.x · Cited by 45 · see citing works

11. Molecular genetics of Alzheimer's disease

Hardy, J., Owen, M. J., Goate, A., James, L., Haynes, A. R., Williamson, R., Roques, P. K., Rossor, M. N., & Mullan, M. J. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0513-2_3 · Cited by 44 · see citing works

Association of the C766T polymorphism of the low‐density lipoprotein receptor‐related protein gene with Alzheimer's disease

Kölsch, H., Ptok, U., Mohamed, I., Schmitz, S., Rao, M. L., Maier, W., & Heun, R. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20043 · Cited by 43 · see citing works

Physical Interaction of ApoE with Amyloid Precursor Protein Independent of the Amyloid Aβ Region in Vitro

Haβ, S., Fresser, F., Köchl, S., Beyreuther, K., Utermann, G., & Baier, G. (1998) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57838-3 · Cited by 41 · see citing works

Alterations in Brain Cholesterol Metabolism in the APPSLxPS1mut mouse, a Model for Alzheimer's Disease

Vanmierlo, T., Bloks, V. W., der Zee, L. C. V. V., Rutten, K., Kerksiek, A., Friedrichs, S., Sijbrands, E. J. G., Steinbusch, H. W. M., Kuipers, F., Lütjohann, D., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1209 · Cited by 40 · see citing works

A novel reciprocal and biphasic relationship between membrane cholesterol and β‐secretase activity in SH‐SY5Y cells and in human platelets

Liu, W. W., Todd, S., Coulson, D. T. R., Irvine, G. B., Passmore, A. P., McGuinness, B., McConville, M., Craig, D., & Johnston, J. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05753.x · Cited by 40 · see citing works

γ-Secretase Cleavage Site Specificity Differs for Intracellular and Secretory Amyloid β

Grimm, H. S., Beher, D., Lichtenthaler, S. F., Shearman, M. S., Beyreuther, K. T., & Hartmann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210380200 · Cited by 39 · see citing works

Cholesterol‐Dependent Aggregation of Amyloid β‐Protein

Yanagisawa, K., & Matsuzaki, K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04841.x · Cited by 39 · see citing works

Brain gangliosides in Alzheimer's disease.

Kraĉun, I., Bognar, S. K., Ćosović, Č., & Talan-Hranilović, J. (1990) · PubMed · Cited by 35 · see citing works

Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes

Chen, S., Lee, J., Zeng, C., Chen, H., Hsu, C. Y., & Xu, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03774.x · Cited by 34 · see citing works

Cholesterol Secoaldehyde, An Ozonation Product of Cholesterol, Induces Amyloid Aggregation and Apoptosis in Murine GT1-7 Hypothalamic Neurons

Sathishkumar, K., Xi, X., Martin, R. J., & Uppu, R. M. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11302 · Cited by 32 · see citing works

Presenilin 1 modifies lipid raft composition of neuronal membranes

Eckert, G. P., & Müller, W. E. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.070 · Cited by 25 · see citing works

Genetic epidemiology of Alzheimerʼs disease

Dartigues, J. F., & Letenneur, L. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00004 · Cited by 20 · see citing works

Sphingomyelinase dependent apoptosis following treatment of pancreatic beta-cells with amyloid peptides Aß1-42 or IAPP

Zhang, Y., Ranta, F., Tang, C., Shumilina, E. V., Mahmud, H., Föller, M., Ullrich, S., Häring, H., & Lang, F. J. W. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0364-4 · Cited by 18 · see citing works

Regulation of the lipidation of β-secretase by statins

Parsons, R. B., Farrant, J. K., Price, G. C., Subramaniam, D., & Austen, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350577 · Cited by 15 · see citing works

Sphingomyelinase dependent apoptosis of dendritic cells following treatment with amyloid peptides

Xuân, N. T., Shumilina, E. V., Kempe, D. S., Gulbins, E., & Lang, F. J. W. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.12.002 · Cited by 14 · see citing works

The broad autism phenotype: A complementary strategy for molecular genetic studies of autism

(2001) · doi:10.1002/1096-8628(20010108)105:1

Linking lipids to Alzheimer's disease: cholesterol and beyond

Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972 · see citing works

Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease

Chan, R. B., Oliveira, T. G., Cortes, E. P., Honig, L. S., Duff, K. E., Small, S. A., Wenk, M. R., Shui, G., & Di Paolo, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274142 · Cited by 630 · see citing works

Lipid Rafts and Alzheimer’s Disease: Protein-Lipid Interactions and Perturbation of Signaling

Hicks, D. A., Nalivaeva, N. N., & Turner, A. J. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00189 · Cited by 205 · see citing works

Roles of AMP-activated Protein Kinase in Alzheimer’s Disease

Cai, Z., Yan, L., Li, K., Quazi, S. H., & Zhao, B. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8173-2 · Cited by 191 · see citing works

Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer’s disease

Lee, J. K., Jin, H. K., Park, M. H., Kim, B.-R., Lee, P. H., Nakauchi, H., Carter, J., He, X., Schuchman, E. H., & Bae, J. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20132451 · Cited by 147 · see citing works

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

Lista, S., Faltraco, F., Prvulovic, D., & Hampel, H. J. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.007 · Cited by 131 · see citing works

Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis

Maulik, M., Westaway, D. A., Jhamandas, J. H., & Kar, S. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8337-y · Cited by 117 · see citing works

Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease

Mast, N., Saadane, A., Valencia‐Olvera, A. C., Constans, J., Maxfield, E., Arakawa, H., Li, Y., Landreth, G. E., & Pikuleva, I. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.026 · Cited by 108 · see citing works

Triangulated Mal-Signaling in Alzheimer's Disease: Roles of Neurotoxic Ceramides, ER Stress, and Insulin Resistance Reviewed

de la Monte, S. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111727 · Cited by 101 · see citing works

β‐Site APP‐cleaving enzyme 1 trafficking and Alzheimer’s disease pathogenesis

Tan, J., & Evin, G. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07623.x · Cited by 87 · see citing works

Dysfunctional Pro-Ceramide, ER Stress, and Insulin/IGF Signaling Networks with Progression of Alzheimer's Disease

de la Monte, S. M., Re, E. B., Longato, L., & Tong, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111728 · Cited by 80 · see citing works

Platelets and Alzheimer’s disease: Potential of APP as a biomarker

Evin, G. M. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i6.102 · Cited by 81 · see citing works

Lipid Metabolism and Glial Lipoproteins in the Central Nervous System

Hayashi, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.453 · Cited by 80 · see citing works

Induction of Mitochondrial Changes Associated with Oxidative Stress on Very Long Chain Fatty Acids (C22:0, C24:0, or C26:0)-Treated Human Neuronal Cells (SK-NB-E)

Zarrouk, A., Véjux, A., Nury, T., Hajj, H. I. E., Haddad, M., Cherkaoui‐Malki, M., Riedinger, J., Hammami, M., & Lizard, G. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/623257 · Cited by 90 · see citing works

Evidence for Premature Lipid Raft Aging in APP/PS1 Double-Transgenic Mice, a Model of Familial Alzheimer Disease

Fabelo, N., Martín, M. V., Marín, R., Santpere, G., Aso, E., Ferrer, I., & Díaz, M. L. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31826be03c · Cited by 75 · see citing works

Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease.

Aly, H. F., Metwally, F. M., & Ahmed, H. H. (2011) · Acta Biochimica Polonica · doi:10.18388/abp.2011_2218 · Cited by 72 · see citing works

The Isoform-Specific Pathological Effects of ApoE4 in vivo are Prevented by a Fish Oil (DHA) Diet and are Modified by Cholesterol

Kariv-Inbal, Z., Yacobson, S., Berkecz, R., Péter, M., Janáky, T., Lütjohann, D., Broersen, L., Hartmann, T., & Michaelson, D. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111265 · Cited by 70 · see citing works

The role of APP proteolytic processing in lipid metabolism

Grimm, M. O. W., Rothhaar, T. L., & Hartmann, T. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2975-6 · Cited by 68 · see citing works

Potential therapeutic target for aging and age-related neurodegenerative diseases: the role of acid sphingomyelinase

Park, M. H., Jin, H. K., & Bae, J.-S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0399-8 · Cited by 59 · see citing works

The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease

Jeynes, B., & Provias, J. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22527 · Cited by 51 · see citing works

Lipid raft disarrangement as a result of neuropathological progresses: A novel strategy for early diagnosis?

Marín, R., Rojo, J. A. P., Fabelo, N., Fernandez, C. E., & Díaz, M. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.025 · Cited by 49 · see citing works

Rational heterodoxy: Cholesterol reformation of the amyloid doctrine

Castello, M. A., & Soriano, S. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.007 · Cited by 44 · see citing works

Amyloid β Dodecamer Disrupts the Neuronal Membrane More Strongly than the Mature Fibril: Understanding the Role of Oligomers in Neurotoxicity

Nguyen, H. L., Linh, H. Q., Krupa, P., Penna, G. L., & Li, M. S. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c01769 · Cited by 41 · see citing works

Statins: The Role in the Treatment and Prevention of Alzheimer's Neurodegeneration

Pac-Soo, C., Lloyd, D. G., Vizcaychipi, M. P., & Ma, D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110524 · Cited by 42 · see citing works

Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s Disease

Grimm, M. O. W., Haupenthal, V. J., Rothhaar, T. L., Zimmer, V. C., Grösgen, S., Hundsdörfer, B., Lehmann, J., Grimm, H. S., & Hartmann, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035879 · Cited by 43 · see citing works

Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype

Lane, R. M., & He, Y. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.005 · Cited by 35 · see citing works

Systematic review of brain and blood lipidomics in Alzheimer's disease mouse models

Ferré‐González, L., Lloret, A., & Cháfer‐Pericás, C. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101223 · Cited by 29 · see citing works

Understanding the Beneficial and Detrimental Effects of Donepezil and Rivastigmine to Improve their Therapeutic Value

Lane, R. M., & Darreh‐Shori, T. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142268 · Cited by 31 · see citing works

Windows into estradiol effects in Alzheimer's disease therapy.

Mohamd, E. M., Ahmed, H. H., Estefan, S. F., Farrag, A. E.-R. H., & Salah, R. S. (2011) · PubMed · Cited by 29 · see citing works

Rabs, SNAREs and α-synuclein — Membrane trafficking defects in synucleinopathies

Chua, C. E. L., & Tang, B. L. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.03.002 · Cited by 28 · see citing works

ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice

Wijesekara, N., Kaur, A., Westwell-Roper, C. Y., Nąckiewicz, D., Soukhatcheva, G., Hayden, M. R., & Verchere, C. B. (2016) · Diabetologia · doi:10.1007/s00125-016-3907-6 · Cited by 27 · see citing works

The Alzheimer's disease amyloid-β peptide affects the size-dynamics of raft-mimicking Lo domains in GM1-containing lipid bilayers

Staneva, G., Puff, N., Stanimirov, S. S., Tochev, T., Angelova, M. I., & Seigneuret, M. (2018) · Soft Matter · doi:10.1039/c8sm01636d · Cited by 27 · see citing works

Microglia-specific regulation of lipid metabolism in Alzheimer’s disease revealed by microglial depletion in 5xFAD Mice

Xu, Z., Shabestari, S. K., Barannikov, S., Bieniek, K. F., Blurton-Jones, M. M., Palavicini, J. P., & Han, X. (2025) · Nature Communications · doi:10.1038/s41467-025-64161-z · Cited by 28 · see citing works

Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment

González‐Escamilla, G., Atienza, M., García-Solís, D., & Cantero, J. L. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0930-6 · Cited by 27 · see citing works

GAPT regulates cholinergic dysfunction and oxidative stress in the brains of learning and memory impairment mice induced by scopolamine

Liu, Z., Qin, G., Mana, L., Dong, Y., Huang, S., Wang, Y., Wu, Y., Shi, J., Tian, J., & Wang, P. (2020) · Brain and Behavior · doi:10.1002/brb3.1602 · Cited by 21 · see citing works

Oestrogens as M odulators of N euronal Si gnalosomes and B rain L ipid H omeostasis R elated to P rotection A gainst N eurodegeneration

Marín, R., Casañas‐Sánchez, V., Pérez, J. A. P., Fabelo, N., Fernandez, C. E., & Díaz, M. L. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12068 · Cited by 20 · see citing works

Ceramide and Related‐Sphingolipid Levels Are Not Altered in Disease‐Associated Brain Regions of APPSL and APPSL/PS1M146L Mouse Models of Alzheimer′s Disease: Relationship with the Lack of Neurodegeneration?

Barrier, L., Fauconneau, B., Noël, A., & Ingrand, S. S. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/920958 · Cited by 19 · see citing works

Dietary composition affects the development of cognitive deficits in WT and Tg AD model mice

Kadish, I., Kumar, A., Beitnere, U., Jennings, E., McGilberry, W., & van Groen, T. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.003 · Cited by 19 · see citing works

Recent Understanding of the Molecular Mechanisms of Alzheimer?s Disease

Grimm, M. O. W., & Hartmann, T. (2011) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s5-004 · Cited by 19 · see citing works

Effect of the Synaptic Plasma Membrane on the Stability of the Amyloid Precursor Protein Homodimer

Audagnotto, M., Lemmin, T., Barducci, A., & Peraro, M. D. (2016) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.6b01721 · Cited by 18 · see citing works

Shotgun lipidomics of liver and brain tissue of Alzheimer’s disease model mice treated with acitretin

Lauer, A. A., Janitschke, D., Guilherme, M. D. S., Nguyen, V. T. T., Bachmann, C. M., Qiao, S., Schrul, B., Boehm, U., Grimm, H. S., Hartmann, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94706-3 · Cited by 18 · see citing works

Amelioration of scopolamine-induced learning and memory impairment by the TRPV4 inhibitor HC067047 in ICR mice

Deng, Y., Li, W., Niu, L., Luo, X., Li, J., Zhang, Y. E., Liu, H., He, J., & Wan, W. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136209 · Cited by 17 · see citing works

Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases

Gouras, G. K. (2013) · International Journal of Cell Biology · doi:10.1155/2013/141083 · Cited by 17 · see citing works

The Impact of ESCRT on Aβ1-42 Induced Membrane Lesions in a Yeast Model for Alzheimer’s Disease

Fruhmann, G., Marchal, C., Vignaud, H., Verduyckt, M., Talarek, N., VIRGILIO, C. D., Winderickx, J., & Cullin, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00406 · Cited by 17 · see citing works

Intertwined Pathologies of Amyloid-β and Metal Ions in Alzheimer’s Disease: Metal–Amyloid-β

Nam, G., & Lim, M.-H. (2019) · Chemistry Letters · doi:10.1246/cl.190281 · Cited by 12 · see citing works

Neuroprotective Effects of Resveratrol by Modifying Cholesterol Metabolism and Aβ Processing in SAMP8 Mice

Sánchez-Melgar, A., Izquierdo-Ramírez, P. J., Griñán‐Ferré, C., Pallàs, M., Martı́n, M., & Albasanz, J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147580 · Cited by 16 · see citing works

Lipids in Alzheimer’s disease and their potential for therapy

Lütjohann, D., Meichsner, S., & Pettersson, H. I. (2012) · Clinical Lipidology · doi:10.2217/clp.11.74 · Cited by 16 · see citing works

Lipids and Alzheimer's disease

Garner, B. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.06.003 · Cited by 16 · see citing works

The impact of capsaicinoids on APP processing in Alzheimer’s disease in SH-SY5Y cells

Grimm, M. O. W., Blümel, T., Lauer, A. A., Janitschke, D., Stahlmann, C. P., Mett, J., Haupenthal, V. J., Miederer, A.-M., Niemeyer, B. A., Grimm, H. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66009-6 · Cited by 15 · see citing works

Ischemic conditions and β-secretase activation: The impact of membrane cholesterol enrichment as triggering factor in rat brain endothelial cells

Brambilla, A., Lonati, E., Milani, C., Rizzo, A. M., Farina, F., Botto, L., Masserini, M., Palestini, P., & Bulbarelli, A. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.10.005 · Cited by 13 · see citing works

Analysis of early effects of human APOE isoforms on Alzheimer’s disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE

Yesiltepe, M., Yin, T., Tambini, M., Bao, H., Pan, M., d’Abramo, C., Giliberto, L., Han, X., & D’Adamio, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01832-2 · Cited by 10 · see citing works

Silent Information Regulator 1/Peroxisome Proliferator‐Activated Receptor‐γ Coactivator‐1α Axis: A Promising Target for Parkinson's and Alzheimer's Disease Therapies

Goyal, A., Kumari, A., Verma, A., Chaudhary, V., Agrawal, V., & Yadav, H. N. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70078 · Cited by 10 · see citing works

NEUROPROTECTIVE EFFECT OF AMORPHOPHALLUS CAMPANULATUS IN STZ INDUCED ALZHEIMER RAT MODEL

Chen, D. (2016) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v13i4.8 · Cited by 10 · see citing works

Resveratrol Attenuates the Disruption of Lipid Metabolism Observed in APP/PS1 Mouse Brains and Cultured Primary Neurons Exposed to Aβ.

Dong, Y.-T., Cao, K., Xiang, J., Qi, X.-L., Xiao, Y., Yu, W.-F., He, Y., Hong, W., & Guan, Z.-Z. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.04.023 · Cited by 4 · see citing works

The novel sphingolipids cP1P and P1P attenuate neuroinflammation and enhance S1PR1/Akt/mTOR signaling to mitigate cognitive decline in an Alzheimer’s disease mouse model

Choe, K., Ahmad, R., Kang, M. H., Lee, H. J., Ahmad, S., Park, T. J., & Kim, M. O. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02485-5 · Cited by 9 · see citing works

Evidence from ITIR-FCS Diffusion Studies that the Amyloid-Beta (Aβ) Peptide Does Not Perturb Plasma Membrane Fluidity in Neuronal Cells

Ng, J. T. Y., Kamm, R. D., Wohland, T., & Kraut, R. S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.030 · Cited by 8 · see citing works

An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer’s Disease

Menta, B. W., & Swerdlow, R. H. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2603-y · Cited by 7 · see citing works

Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer’s Disease

Khavinson, V. K., Linkova, N. S., & Umnov, R. S. (2021) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-021-05192-6 · Cited by 7 · see citing works

Amyloid-β Interactions with Lipid Rafts in Biomimetic Systems: A Review of Laboratory Methods

Staneva, G., WATANABE, C., Puff, N., Yordanova, V., Seigneuret, M., & Angelova, M. I. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0814-2_4 · Cited by 7 · see citing works

Understanding Alzheimer disease

Vally, M., & Kathrada, F. (2019) · South African Family Practice · doi:10.4102/safp.v61i2.4999 · Cited by 6 · see citing works

Characterization of the interactions between β‐amyloid peptide and the membranes of human SK‐N‐SH cells

Liu, R., Tian, T., & Jia, J. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.035 · Cited by 5 · see citing works

Cholesterol and Fat Metabolism in Alzheimer’s Disease

Taghibiglou, C., & Khalaj, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00009-x · Cited by 5 · see citing works

The Effects of Glycerophospholipids and Fatty Acids on APP Processing

Mett, J., Hartmann, T., & Grimm, M. O. W. (2016) · Elsevier eBooks · doi:10.1016/b978-1-63067-036-8.00013-5 · Cited by 5 · see citing works

Metabolomics in the Study of Alzheimer's Disease

Ibáñez, C., Valdés, A., García‐Cañas, V., & Simó, C. (2014) · Comprehensive analytical chemistry · doi:10.1016/b978-0-444-62650-9.00010-5 · Cited by 4 · see citing works

Hypothalamic aging and hormones

Cai, Z.-J. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2020.12.002 · Cited by 7 · see citing works

“Hot Spots” in Medicinal Chemistry

Metternich, R. E., & Tarzia, G. (2010) · ChemMedChem · doi:10.1002/cmdc.201000266 · Cited by 4 · see citing works

On the possible structural role of single chain sphingolipids Sphingosine and Sphingosine 1-phosphate in the amyloid-β peptide interactions with membranes. Consequences for Alzheimer’s disease development

WATANABE, C., Seigneuret, M., Staneva, G., Puff, N., & Angelova, M. I. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.04.027 · Cited by 4 · see citing works

Multiomic Evidence for a Unified Model of Alzheimer’s Disease Etiology Linking Microglial Flux Capacity and Astrocyte-Neuron Metabolic BreakdownPreprint

Paterson, T., Rohrs, J. A., Hohman, T. J., Mapstone, M. E., Meikle, P. J., Kaddurah‐Daouk, R., Levey, A. I., Hood, L., Initiative, A. D. N., & Funk, C. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.23.604835 · Cited by 3 · see citing works

The ABCA7 transporter, brain lipids and Alzheimer’s disease

Soscia, S. J., & Fitzgerald, M. L. (2013) · Clinical Lipidology · doi:10.2217/clp.12.91 · Cited by 3 · see citing works

Genetic markers of cholesterol transport and gray matter diffusion: a preliminary study of the CETP I405V polymorphism

Salminen, L. E., Schofield, P. R., Pierce, K. D., Luo, X., Zhao, Y., Laidlaw, D. H., Cabeen, R. P., Conturo, T. E., Lane, E., Heaps, J. M., et al. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1434-0 · Cited by 3 · see citing works

Niemann-Pick Type C Disease: At the Nexus of Neurodegenerative and Neurodevelopmental Disorders

(2020) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000029 · Cited by 2 · see citing works

Alzheimer's Disease: Approaches to Pathogenesis in the Genomic Age

Sutherland, G. T., & Jillian, J. (2012) · InTech eBooks · doi:10.5772/36505 · Cited by 2 · see citing works

The Therapeutic Role of Turmeric in Treatment and Prevention of Alzheimer’s Disease

McQuade, R. M. (2015) · SEU FIRE Scholars (Southeastern University) · Cited by 1 · see citing works

Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential

Gutiérrez‐Merino, C. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100672 · Cited by 2 · see citing works

Potential Candidate Genes and Pathways Affecting the Metabolism of Jaw Fats in Risso’s Dolphin: Based on TranscriptomicsPreprint

Senevirathna, J. D. M., Yonezawa, R., Igarashi, Y., Saka, T., Yoshitake, K., Kinoshita, S., Funasaka, N., & Asakawa, S. (2021) · Research Square · doi:10.21203/rs.3.rs-144280/v1 · Cited by 1 · see citing works

The Role of Lipoproteins/cholesterol in Genomic Instability and Chromosome Mis-segregation in Alzheimer's and Cardiovascular Disease

Granic, A. (2011) · Digital Commons - University of South Florida (University of South Florida)

STUDY OF INHIBITION OF Aβ42 AGGREGATION AND OLIGOMER FORMING WITH DOCKING AND MD SIMULATION

Khandan, V., Bahar, F., & Said, S. M. (2015)

Deciphering the role of 27-hydroxycholesterol in neurodegeneration

Ismail, M. A. M. (2016) · Figshare

The effect of the amyloid-beta peptide on the fluidity of cell membranes : a study by fluorescence correlation spectroscopy

Ng, J. W. Q. (2017) · doi:10.32657/10356/70210

ANTI-ALZHEIMER ACTIVITY OF TACRINE LOADED METHOXYPOLY (ETHYLENE GLYCOL) POLY (CAPROLACTONE) NANOPARTICLES

Joe, F., & Kumar, S. S. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11s4.31730

Amyloid beta: from pre-analytical factors to disease mechanisms

Toombs, J. (2019) · UCL Discovery (University College London)

Changing fate

Reinhardt, S., & Endres, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00039-2

Assessment of Epigenetic profile in Alzheimer's disease

Agbemenyah, H. Y. (2012) · doi:10.53846/goediss-3213

Sterol Biomarker Discovery In Neurodegenerative Diseases

Pacciarini, M. (2023) · doi:10.23889/suthesis.65375

Microglia-Dependent and Independent Modulation of Brain Lipid Metabolism in Alzheimer’s Disease Revealed by Pharmacological and Genetic Microglial DepletionPreprint

Xu, Z., Shabestari, S. K., Barannikov, S., Bieniek, K. F., Blurton-Jones, M. M., Palavicini, J. P., & Han, X. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.18.624173

Heparin and fluoride drive distinct tau (4R/1 N) aggregation pathways to fibrils and granular oligomers, as revealed by Raman spectroscopy

Rouhbakhsh, H., Farkhari, N., Khatami, S. H., Ehtiati, S., Hosseini, M. M., Soleimani, Y., Rashidi, M., Tajalli, H., Ahmadi-Kandjani, S., Boostanipour, A., et al. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2598636

Targeting the peripheral immune system for treatment of Alzheimer’s disease

Almasarani, E., Fog, M. H., Vorup‐Jensen, T., & Juul‐Madsen, K. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00054-9

Genetic Ablation of the Platelet Activating Factor Receptor Does Not Impair Learning and Memory in Wild-Type Mice or Alter Amyloid Plaque Number in a Transgenic Model of Alzheimer’s Disease

Peshdary, V. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-5394

Toll-Like Receptor 2 and Partner Receptors in Alzheimers Disease

Shirong, L. (2011) · Publications of the UdS (Saarland University) · doi:10.22028/d291-21508

Alzheimer's disease amyloid precursor protein and amyloid beta peptides are key regulators of brain lipid composition

Grimm, M. O. W. (2010) · Frontiers in Neuroscience · doi:10.3389/conf.fnins.2010.10.00211

Amyloid beta-protein and lipid metabolism

Zinser, E. G., Hartmann, T., & Grimm, M. O. W. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.014 · Cited by 55 · see citing works

APP Function and Lipids: A Bidirectional Link

Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104 · see citing works

The role of APP proteolytic processing in lipid metabolism

Grimm, M. O. W., Rothhaar, T. L., & Hartmann, T. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2975-6 · Cited by 68 · see citing works

www.elsevier.com/locate/bbamem Review Amyloid beta-protein and lipid metabolism

Zinser, E. G., Hartmann, T., & Grimm, M. O. W. (2007)